Emerging concerns link GLP-1 use, found in weight loss drugs like Wegovy/Ozempic and Mounjaro, to potential thyroid cancer ...

Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...

Kilow, Saudi Arabia’s leading digital health and weight loss platform, is proud to announce the official launch of Kilow ...

Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...

In a new book, Mallary Tenore Tarpley says she's learned to reject perfectionism when it comes to recovery and accept her ...

Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

Americans are flocking to new weight loss medications like Novo Nordisk’s Wegovy and Eli Lilly's Zepbound, which work by ...

Ohio’s decision to end GLP-1 coverage for state employees is unjustified and harmful, writes Dr. Leslie Pristas, president of ...

It has been a rough few seasons for Novo Nordisk (NYSE:NVO) investors, as the company’s share price has tumbled some 60% over ...

Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...

Researchers at the Salk Institute have used CRISPR to uncover hidden microproteins that control fat cell growth and lipid ...

In a letter sent to Harvard President Alan M. Garber on Friday, Commerce Secretary Howard Lutnick alleges the university ...